Related Experiment Video
Updated: Mar 23, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
p38MAPK activation and DUSP10 expression in meningiomas
Mahlon D Johnson1, Jay E Reeder2, Mary O'Connell1
1Department of Pathology, Division of Neuropathology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, NY 14623, USA.
Abstract:
The mitogen activated protein kinase (MAPK) p38MAPK has been implicated in regulation of cell proliferation and apoptosis. However, expression, activation and regulation has not been studied in meningiomas, to our knowledge. p38MAPK is regulated, in part, by dual specificity phosphatases (DUSP) that inactivate signaling by dephosphorylation. DUSP10 is also a likely participant in regulating meningioma proliferation. Five fetal and an adult human leptomeninges and 37 meningioma cultures (MC) were evaluated for DUSP10 as well as phosphorylation of its substrates p38MAPK and p44/42MAPK by western blot and DUSP10 expression by polymerase chain reaction. Platelet derived growth factor-BB (PDGF-BB), transforming growth factor B1 (TGFB1) and cerebrospinal fluid effects on DUSP10 and signaling were also studied in vitro. DUSP10 and phospho-p38MAPK and phospho-p44/42MAPK were detected in all six leptomeninges. DUSP10 was detected in 13 of 17 World Health Organization grade I, 11 of 14 grade II and four of six grade III meningiomas. Phospho-p38MAPK was detected in nine of 17 grade I, two of six grade II, and four of six grade III meningiomas. In the majority of meningiomas DUSP10 expression correlated inversely with phosphorylation of p38MAPK. PDGF-BB increased DUSP10 in MC2 and MC4 and weakly in MC3. TGFB1 increased phosphorylation of p38MAPK and caspase 3 activation. Thus p38MAPK and DUSP10 likely participate in the pathogenesis of meningiomas.
Insights
Mitogen-activated protein kinase (MAPK) p38MAPK and dual-specificity phosphatase 10 (DUSP10) are involved in meningioma cell growth. DUSP10 expression inversely correlates with p38MAPK phosphorylation in most meningiomas, suggesting a role in tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Mitogen-activated protein kinase (MAPK) p38MAPK is crucial for cell proliferation and apoptosis.
- The role of p38MAPK, its activation, and regulation by dual-specificity phosphatases (DUSP), specifically DUSP10, in meningiomas remains uncharacterized.
- DUSP10 is a potential regulator of meningioma cell proliferation.
Purpose of the Study:
- To investigate the expression, activation, and regulation of DUSP10 and p38MAPK signaling in human meningiomas.
- To explore the in vitro effects of platelet-derived growth factor-BB (PDGF-BB) and transforming growth factor B1 (TGFB1) on DUSP10 and MAPK signaling in meningioma cultures.
Main Methods:
- Western blot analysis was used to detect DUSP10 and phosphorylated p38MAPK and p44/42MAPK.
- Polymerase chain reaction (PCR) was employed to assess DUSP10 expression.
- In vitro studies examined the effects of PDGF-BB, TGFB1, and cerebrospinal fluid on meningioma cells.
Main Results:
- DUSP10 and phosphorylated p38MAPK/p44/42MAPK were present in normal leptomeninges and meningiomas across all World Health Organization grades.
- DUSP10 expression generally showed an inverse correlation with p38MAPK phosphorylation in meningiomas.
- PDGF-BB upregulated DUSP10, while TGFB1 increased p38MAPK phosphorylation and caspase 3 activation.
Conclusions:
- p38MAPK and DUSP10 are likely involved in the pathogenesis of meningiomas.
- The interplay between DUSP10 and p38MAPK signaling pathways may represent a therapeutic target for meningioma treatment.
Related Concept Videos
MAPK Signaling Cascades
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

